| 173.94 Delayed Data As of Feb 21 |  -2.74 / -1.55%Today’s Change | 123.00 Today|||52-Week Range 178.68 | +13.56% Year-to-Date |
| Edwards Lifesciences to Buy CASMED to Boost Critical Care Arm Feb 13 / Zacks.com - Paid Partner Content | Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar? Feb 12 / Zacks.com - Paid Partner Content |
| Previous close | 176.68 |
| Today’s open | 176.34 |
| Day’s range | 172.71 - 176.47 |
| Volume | 1,473,383 |
| Average volume (3 months) | 1,473,238 |
| Market cap | $37.0B |
| Earnings growth (last year) | +6.23% |
| Earnings growth (this year) | +10.74% |
| Earnings growth (next 5 years) | +15.69% |
| Revenue growth (last year) | +8.37% |
| P/E ratio | 51.5 |
| Price/Sales | 8.79 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| SNNSmith & Nephew PLC | -0.39 | -1.02% |
| STESTERIS plc | -0.47 | -0.38% |
| HRCHill-Rom Holdings In... | -0.68 | -0.65% |
| ISRGIntuitive Surgical | +0.22 | +0.04% |
| Next reporting date | April 23, 2019 |
| EPS forecast (this quarter) | $1.24 |
| Annual revenue (last year) | $3.7B |
| Annual profit (last year) | $722.2M |
| Net profit margin | 19.40% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Michael A. Mussallem |
Chief Financial Officer & Vice President Scott B. Ullem |
Corporate headquarters Irvine, California |
